SM
IONS icon

Sabby Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sabby Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-846
Closed -$2.84M – 197
2021
Q3 		$2.84M Buy
846
+5
+0.6% +$188 0.38% 39
2021
Q2 		$3.35M Buy
841
+11
+1% +$431 0.47% 26
2021
Q1 		$3.73M Buy
830
+618
+292% +$34.5K 0.73% 24
2020
Q4 		$1.2M Hold
212
– – 0.23% 45
2020
Q3 		$1.01M Buy
212
+44
+26% +$2.44K 0.15% 65
2020
Q2 		$991K Buy
+168
New +$9.35K 0.2% 46
2018
Q1 		– Sell
-1,230
Closed -$6.19M – 170
2017
Q4 		$6.19M Sell
1,230
-382
-24% -$20.9K 0.56% 31
2017
Q3 		$8.17M Buy
1,612
+353
+28% +$18.5K 0.53% 24
2017
Q2 		$6.41M Sell
1,259
-1,264
-50% -$58.9K 0.42% 34
2017
Q1 		$10.1M Buy
2,523
+1,786
+242% +$80.2K 0.55% 32
2016
Q4 		$3.52M Hold
737
– – 0.21% 71
2016
Q3 		$2.7M Sell
737
-247
-25% -$7.73K 0.1% 105
2016
Q2 		$2.29M Buy
984
+798
+429% +$25.7K 0.12% 100
2016
Q1 		$753K Buy
+186
New +$7.55K 0.04% 180
2015
Q2 		– Sell
-65
Closed -$414K – 344
2015
Q1 		$414K Buy
+65
New +$4.41K 0.02% 243
2014
Q2 		– Sell
-2,078
Closed -$8.98M – 275
2014
Q1 		$8.98M Sell
2,078
-258
-11% -$12.5K 0.5% 45
2013
Q4 		$9.31M Buy
2,336
+1,334
+133% +$47.5K 0.59% 36
2013
Q3 		$3.76M Buy
+1,002
New +$29.9K 0.24% 61

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Sabby Management's IONS Position: Q4 2021 in Review

Sabby Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 84,600 shares — an estimated $2.84M sold.

Sabby Management first reported a position in IONS in Q3 2013 and held it in 7 quarters. The position peaked at $4.65M in Q1 2017. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • Sabby Management reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Sabby Management sold 84,600 Ionis Pharmaceuticals shares in Q4 2021, an estimated $2.84M.
  • Sabby Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Sabby Management's Ionis Pharmaceuticals position peaked at $4.65M in Q1 2017.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.